First Citizens Bank & Trust CO Charles River Laboratories International, Inc. Transaction History

First Citizens Bank & Trust CO

  • $6.53 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022
SELL
$204.13 - $302.4 $301,704 - $446,947
-1,478 Closed
0 $0
Q1 2022

Apr 26, 2022
SELL
$255.51 - $362.11 $45,480 - $64,455
-178 Reduced 10.75%
1,478 $420,000
Q4 2021

Mar 11, 2022
BUY
$351.38 - $448.68 $6,324 - $8,076
18 Added 1.1%
1,656 $624,000
Q3 2021

Oct 15, 2021
BUY
$372.64 - $458.3 $71,919 - $88,451
193 Added 13.36%
1,638 $676,000
Q2 2021

Jul 14, 2021
BUY
$294.17 - $371.65 $425,075 - $537,034
1,445 New
1,445 $535,000

Others Institutions Holding CRL

# of Institutions
696
Shares Held
52.3M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track First Citizens Bank & Trust CO Portfolio

Follow First Citizens Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Bank & Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email